Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Northwest Bioth Cmn (OP: NWBO )

0.6400 -0.0030 (-0.47%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Northwest Bioth Cmn

Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation
Via ACN Newswire
Topics Law Enforcement Lawsuit
Exposures Financial Legal
NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit
Shares of NWBO stock are rallying on Thursday, as Northwest Biotherapeutics sues a number of Wall Street firms for stock manipulation. 
Via InvestorPlace
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
While July gave markets around the world a breather, August reestablished 2022’s choppy financial conditions. 
Via Benzinga
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share... 
Via Benzinga
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
Reflecting the expected conditions of a bear market, many of the world’s indices saw a decrease in price throughout June. 
Via Benzinga
The OTC Markets' Most-Active Securities Embrace International Operators As Volatility Envelops Markets In May
Reflecting the world’s uncertainty about the U.S. economy, the market’s major indices saw incredible volatility in May. 
Via Benzinga
If You Invested $1000 In Northwest Biotherapeutics 5 Years Ago, Here's How Much You Would Have Today
Northwest Biotherapeutics (OTC:NWBO) has outperformed the market over the past 5 years by 42.99% on an annualized basis producing an average annual return of 54.57%. Currently, Northwest... 
Via Benzinga
Northwest Biotherapeutics, Inc. (OTC:NWBO) Investor Notice: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 04/28/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Northwest Biotherapeutics, Inc. 
Via SBWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.